MT-RNR2 and neoplasm: Thus, a recent study has reported that HN might be tumor promoting in triple-negative breast cancer, because HN antagonizes the proapoptotic Bax [78], while silencing of HN expression has been proposed as a therapeutic approach to treat pituitary tumors [79].